Business Description
BioCardia is a Sunnyvale, California-based medical company focused on developing treatments that use living cells to repair damage caused by heart and lung disease. Its most advanced treatment, CardiAMP, uses a patient's own cells to address severe heart failure and is currently in a Phase III clinical trial. The company also has several other therapies in earlier stages of testing, including treatments using donor stem cells for heart failure and respiratory conditions. Alongside its therapies, BioCardia offers specialized tools that help doctors deliver treatments precisely and safely to the heart.
